Both in Pharmaceuticals
Alnylam Pharmaceuticals vs Insmed
Over the past year ALNY returned −63.8% and INSM returned −40.6%; their daily moves had a correlation of 0.03.
ALNY −63.8% INSM −40.6%Growth of $1, one year, split-adjusted
| Metric | ALNY | INSM |
|---|---|---|
| Price | $165.00 | $112.58 |
| Market cap | $22.10B | $24.70B |
| Today | −5.17% | +0.89% |
| 1 month | −28.6% | +3.7% |
| 6 months | −44.3% | −15.5% |
| Year to date | −58.5% | −35.3% |
| 1 year | −65.7% | −32.6% |
| Revenue growth (YoY) | +16.7% | +268.4% |
| Gross margin | 75.2% | 85.1% |
| Net margin | 148.6% | −19.1% |
| P/E (TTM) | 8.1× | — |
| Price / sales | 4.4× | 16.3× |
| Net cash | $2.57B | $569.9M |
| Dividend yield | — | — |
| Volatility (60d) | 72.5% | 46.7% |
| Short % of float | 4.9% | 6.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).